CDC mobilizes globally as Ebola resurges in Congo, exposing U.S. troops.

The Centers for Disease Control and Prevention (CDC) has initiated a global mobilization to address a resurgent Ebola outbreak in Africa, following reports that a small number of Americans stationed in the Democratic Republic of the Congo (DRC) may have been exposed to the virus. In a Sunday announcement, the agency confirmed that while the specific count of exposed U.S. citizens remains unspecified, they are believed to have come into contact with the pathogen during the latest flare-up in the region.

The current epidemic is driven by the Bundibugyo strain and has already claimed 88 lives within the DRC, alongside 10 confirmed and 336 suspected cases. Neighboring Uganda is also grappling with the crisis, recording two confirmed infections and one fatality. This marks the 17th Ebola outbreak recorded in the DRC since the disease was first identified there in 1976. The situation has been particularly severe in previous years, with outbreaks in eastern Congo during 2018 and 2020 each surpassing 1,000 deaths, and the historic 2014-2016 West Africa crisis resulting in over 28,600 cases.

Despite the gravity of the situation, the CDC emphasized that the risk to the general American public remains low, noting there are no confirmed or suspected cases within the United States. The virus transmits exclusively through direct contact with the bodily fluids of an infected individual or contaminated objects, rather than through casual interaction or the air. Nevertheless, the agency is actively coordinating with the Ministries of Health in the DRC and Uganda to support response efforts immediately following notification of the outbreak.

To mitigate the spread, the CDC announced on Monday that it will intensify screening and monitoring protocols for travelers arriving from affected zones. Furthermore, non-U.S. passport holders who have visited Uganda, the DRC, or South Sudan within the past 21 days face travel restrictions. The agency is working with airlines, international partners, and port officials to identify and manage potentially exposed individuals. Simultaneously, the CDC is assisting interagency partners in safely withdrawing a small group of Americans directly affected by the outbreak.

Travelers are urged to heed a Level 2 advisory for the DRC, which calls for enhanced precautions. This includes avoiding contact with individuals displaying symptoms such as fever, muscle pain, and rash, as well as steering clear of blood and body fluids. Visitors must also exercise extreme caution around animals, specifically bats, forest antelopes, and primates, avoiding contact with them or consuming their blood, fluids, or meat. Additionally, anyone leaving the DRC must monitor their health for symptoms for 21 days.

While the World Health Organization has stated the current outbreak does not currently meet the criteria for a pandemic emergency, bordering nations like Rwanda and Uganda face an elevated risk of further transmission. Compounding the urgency, the Bundibugyo virus responsible for this specific outbreak lacks targeted vaccines or treatments, underscoring the critical need for rapid containment and careful management of travel and public health threats.

A health worker undergoes disinfection after leaving an Ebola treatment center in the Democratic Republic of Congo during the 2018 outbreak. Another worker dons protective gear while battling the crisis in 2018. Patients exhibit fever, headache, muscle pain, weakness, diarrhea, vomiting, abdominal pain, and unexplained bleeding. Untreated Ebola carries a mortality rate as high as 90 percent. This new outbreak stems from the Bundibugyo virus, a rare strain lacking approved treatments or vaccines. Scientists have linked this strain to only two prior outbreaks in 2007 and 2012. Mortality rates for Bundibugyo range between 25 and 50 percent. The Zaire strain, the most common form, responds to drugs like Inmazeb and Ebanga. Medical teams also use the Ervebo vaccine, which deploys solely during outbreaks. 'Unfortunately, Bundibugyo has fewer proven countermeasures than Zaire ebolavirus, where vaccines have been highly effective in controlling outbreaks,' said Amanda Rojek, an Associate Professor at the University of Oxford. The World Health Organization confirmed Sunday that a Congolese health worker developed symptoms on April 24. Two infected individuals traveled separately from the DRC to Kampala, Uganda's capital. One of those travelers died in Uganda. Officials report no evidence of ongoing transmission within Uganda.